Fischer Medical Ventures touches roof on planning to raise funds
Fischer Medical Ventures is currently trading at its upper circuit limit of Rs. 734.80, up by 34.90 points or 4.99% from its previous closing of Rs. 699.90 on the BSE.
The scrip opened at Rs. 734.85 and has touched a high and low of Rs. 734.85 and Rs. 725.85 respectively. So far 1240 shares were traded on the counter.
The BSE group 'T' stock of face value Rs. 10 has touched a 52 week high of Rs. 792.65 on 14-Jun-2024 and a 52 week low of Rs. 229.20 on 29-Dec-2023.
Last one week high and low of the scrip stood at Rs. 779.95 and Rs. 691.70 respectively. The current market cap of the company is Rs. 3931.45 crore.
The promoters holding in the company stood at 74.91%, while Institutions and Non-Institutions held 6.75% and 18.33% respectively.
Fischer Medical Ventures is planning to raise funds by way of preferential issue / private placement of securities for cash / other than cash, including determination of Issue Price subject to such regulatory/statutory approvals as may be required, including the approval of shareholders of the Company. A meeting of the Board of Directors of the Company is scheduled to be held on January 03, 2025, inter alia, to consider and approve the same.
Fischer Medical Ventures is engaged in the trading of certain grades of Laboratory Chemicals.
